News | August 18, 2023
BASF, Promega and Swiss TPH collaborate to drive research for malaria control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Jeet will be a trusted partner in cardiovascular care
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
